These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 27894236)

  • 1. Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.
    Kane TL; Carothers KE; Lee SW
    Curr Drug Targets; 2018; 19(2):111-127. PubMed ID: 27894236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies.
    Hsieh RC; Liu R; Burgin DJ; Otto M
    Expert Rev Anti Infect Ther; 2023; 21(9):911-928. PubMed ID: 37501364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity and virulence of
    Cheung GYC; Bae JS; Otto M
    Virulence; 2021 Dec; 12(1):547-569. PubMed ID: 33522395
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Bashabsheh RHF; Al-Fawares O; Natsheh I; Bdeir R; Al-Khreshieh RO; Bashabsheh HHF
    Pathog Glob Health; 2024 May; 118(3):209-231. PubMed ID: 38006316
    [No Abstract]   [Full Text] [Related]  

  • 5. Identifying potential therapeutic targets of methicillin-resistant Staphylococcus aureus through in vivo proteomic analysis.
    Diep BA; Phung Q; Date S; Arnott D; Bakalarski C; Xu M; Nakamura G; Swem DL; Alexander MK; Le HN; Mai TT; Tan MW; Brown EJ; Nishiyama M
    J Infect Dis; 2014 May; 209(10):1533-41. PubMed ID: 24280367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic strategies to combat staphylococcal infections.
    Ohlsen K; Lorenz U
    Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative therapies in Staphylococcus aureus diseases.
    Kurlenda J; Grinholc M
    Acta Biochim Pol; 2012; 59(2):171-84. PubMed ID: 22577619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital.
    Manara S; Pasolli E; Dolce D; Ravenni N; Campana S; Armanini F; Asnicar F; Mengoni A; Galli L; Montagnani C; Venturini E; Rota-Stabelli O; Grandi G; Taccetti G; Segata N
    Genome Med; 2018 Nov; 10(1):82. PubMed ID: 30424799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norwogonin aids in fighting MRSA-induced pneumonia by targeting agrA
    Liu C; Hou J; Ren X; Guo X; Wang B; Song W; Wang L; Wang G
    World J Microbiol Biotechnol; 2024 Jul; 40(9):265. PubMed ID: 38990361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
    Waters EM; Rudkin JK; Coughlan S; Clair GC; Adkins JN; Gore S; Xia G; Black NS; Downing T; O'Neill E; Kadioglu A; O'Gara JP
    J Infect Dis; 2017 Jan; 215(1):80-87. PubMed ID: 28077586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus.
    Abbas HA; Atallah H; El-Sayed MA; El-Ganiny AM
    Arch Microbiol; 2020 Dec; 202(10):2751-2760. PubMed ID: 32737541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics and virulence gene profiles of Staphylococcus aureus isolates in Hainan, China.
    Li X; Huang T; Xu K; Li C; Li Y
    BMC Infect Dis; 2019 Oct; 19(1):873. PubMed ID: 31640587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal Biosynthesis Inhibition with Ambuic Acid as a Strategy To Target Antibiotic-Resistant Infections.
    Todd DA; Parlet CP; Crosby HA; Malone CL; Heilmann KP; Horswill AR; Cech NB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models for infectious diseases caused by Staphylococcus aureus.
    Kim HK; Missiakas D; Schneewind O
    J Immunol Methods; 2014 Aug; 410():88-99. PubMed ID: 24769066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development.
    Morell EA; Balkin DM
    Yale J Biol Med; 2010 Dec; 83(4):223-33. PubMed ID: 21165342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus: a pathogen with still unresolved issues.
    Rasigade JP; Vandenesch F
    Infect Genet Evol; 2014 Jan; 21():510-4. PubMed ID: 23994773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal Pneumonia.
    Jing S; Kong X; Wang L; Wang H; Feng J; Wei L; Meng Y; Liu C; Chang X; Qu Y; Guan J; Yang H; Zhang C; Zhao Y; Song W
    Microbiol Spectr; 2022 Apr; 10(2):e0234021. PubMed ID: 35319277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational drugs to treat methicillin-resistant Staphylococcus aureus.
    Vuong C; Yeh AJ; Cheung GY; Otto M
    Expert Opin Investig Drugs; 2016; 25(1):73-93. PubMed ID: 26536498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.
    Kim HK; Cheng AG; Kim HY; Missiakas DM; Schneewind O
    J Exp Med; 2010 Aug; 207(9):1863-70. PubMed ID: 20713595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.